Sahil Mahajan
About Sahil Mahajan
Data last updated:
Sahil Mahajan is a Director at Ravenbhel Health Care Private Limited (since 2003), Director at Macmillon Pharmaceuticals Private Limited (since 2019) and Director at Ravenbhel Pharmaceuticals Private Limited (since 2022), and holds 9 more current directorships. The companies operate in Pharma, Healthcare and Paper. The 7 current companies with reported revenue have a combined latest revenue of ₹417 Cr; the largest is Ravenbhel Health Care Private Limited at ₹291 Cr (FY 2025). Earlier, Sahil Mahajan was a Director at Novachem Health Care Private Limited (from 2006).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Ravenbhel Health Care Private Limited U24232JK2003PTC002286 | Director | 23 Apr 2003 | 2003 | ₹291 Cr (FY 2025) | Active |
 Macmillon Pharmaceuticals Private Limited U24231PB1988PTC008661 | Director | 01 Sep 2019 | 1988 | ₹83.91 Cr (FY 2024) | Active |
 Ravenbhel Pharmaceuticals Private Limited U24232PB2000PTC024120 | Director | 30 Jul 2022 | 2000 | ₹25.73 Cr (FY 2024) | Active |
 Neomac Pharmaceuticals Private Limited U24232PB2015PTC039375 | Director | 28 Aug 2019 | 2015 | ₹8.43 Cr (FY 2024) | Active |
 Ravenmac Pharmaceuticals Private Limited U24232PB2010PTC033648 | Director | 28 Aug 2019 | 2010 | ₹7.34 Cr (FY 2025) | Active |
| Salutem Pharmaceuticals Private Limited U24290JK2016PTC009772 | Director | 13 Oct 2016 | 2016 | ₹24.9 Lakh (FY 2025) | Active |
| Biovonic Healthcare Private Limited U24299JK2021PTC012575 | Director | 23 Jul 2021 | 2021 | ₹57,600 (FY 2024) | Active |
| Cellopharma Research Private Limited U47721PB2025PTC066069 | Director | 18 Oct 2025 | 2025 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Novachem Health Care Private Limited U24231PB2001PTC024793 | Director | 30 Nov 2006 | 2001 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Sahil Mahajan
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sahil Mahajan
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sahil Mahajan
Sahil Mahajan currently holds 12 directorships: Ravenbhel Health Care Private Limited (Director, since 23 Apr 2003, revenue ₹291 Cr (FY 2025)); Macmillon Pharmaceuticals Private Limited (Director, since 01 Sep 2019, revenue ₹83.91 Cr (FY 2024)); Ravenbhel Pharmaceuticals Private Limited (Director, since 30 Jul 2022, revenue ₹25.73 Cr (FY 2024)); Neomac Pharmaceuticals Private Limited (Director, since 28 Aug 2019, revenue ₹8.43 Cr (FY 2024)); Ravenmac Pharmaceuticals Private Limited (Director, since 28 Aug 2019, revenue ₹7.34 Cr (FY 2025)); and 7 more.
Sahil Mahajan was first appointed on 23 Apr 2003 as Director at Ravenbhel Health Care Private Limited. The most recent appointment on record is 18 Oct 2025 at Cellopharma Research Private Limited.
The 7 current companies of Sahil Mahajan that report revenue have a combined latest revenue of ₹417 Cr: Ravenbhel Health Care Private Limited ₹291 Cr (FY 2025); Macmillon Pharmaceuticals Private Limited ₹83.91 Cr (FY 2024); Ravenbhel Pharmaceuticals Private Limited ₹25.73 Cr (FY 2024); Neomac Pharmaceuticals Private Limited ₹8.43 Cr (FY 2024); Ravenmac Pharmaceuticals Private Limited ₹7.34 Cr (FY 2025); and 2 more.
Sahil Mahajan held 1 earlier board appointment: Novachem Health Care Private Limited (Director, from 30 Nov 2006).
The current boards of Sahil Mahajan's companies include Inam Ur Rehman (Ravenbhel Health Care Private Limited), Mandeep Singh Bhamra (Ravenbhel Health Care Private Limited), Asar Mohd Khan (Macmillon Pharmaceuticals Private Limited), Naresh Mahajan (Macmillon Pharmaceuticals Private Limited), Satish Kumar (Macmillon Pharmaceuticals Private Limited), Sanjay Khanna (Ravenbhel Pharmaceuticals Private Limited), among others.